Pharmadule Morimatsu AB has received an
order from a Chinese corporation to execute a Conceptual &
Basic Design study for a new Biopharmaceutical MAB production
facility project in China. The
extended study will involve engineering departments both in
Stockholm and Shanghai offices.
The study will be completed during Q1
2017. The scope of delivery includes the following disciplines:
Process, Facility, Quality and
Regulatory.
This project is another most
successful prove of that Pharmadule Morimatsu modular facility
solutions/ process equipment's and engineering services is highly
attractive on the worldwide market. The company won this order in
high competition by other International and well recognized
engineering and equipment providers.